3/8/2013

The FDA is reviewing Edwards Lifesciences' request to extend by 1,757 days the patent covering the company's Sapien transcatheter aortic valve implant, which was approved by the agency in November 2011. The agency will accept public comments on the patent extension request through April 23.

Related Summaries